Apelis price in bangladesh

Alpelisib (Alpelisib) is an anti-tumor drug developed by Novartis and is a phosphatidylinositol-3 kinase (PI3K) inhibitor. It exerts anti-tumor effects by inhibiting PI3Kα (PIK3CA) activity and inducing increased transcription of estrogen receptors in breast cancer cells. Apelvis has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of men and postmenopausal women with hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) advanced metastatic breast cancer harboring PIK3CA mutations in combination with fulvestrant.

As for Apelvis in Bangladesh, due to possible differences in drug supervision, production processes and quality control standards in different regions, its quality and effects may be different from the original drug. When choosing drugs, patients should give priority to purchasing them through formal channels and follow their doctors’ recommendations and guidance. At the same time, as with any drug, patients should remain vigilant, pay attention to possible adverse reactions, and consult a doctor promptly if any discomfort occurs. However, there is currently no Bangladeshi version of the original drug or generic version of Apelvis on the market.

The original version of Apelis is currently available overseas in European version and Indian version. Common specifications are 150mg*56 tablets per box and 150mg*28 tablets per box. The price per box may range from 5,000 to more than 40,000 RMB (the price may fluctuate due to the exchange rate). The generic version of Peris has also been launched in some overseas countries. Its pharmaceutical ingredients are basically the same as those of the original drug. For example, the specifications produced by Lucius Pharmaceutical Factory in LaosThe price of 150mg*28 tablets per box may be more than 2,000 yuan (the price may fluctuate due to the exchange rate).